Talphera (TLPH) Cash from Financing Activities (2010 - 2026)

Talphera (TLPH) recorded quarterly Cash from Financing Activities of $4.0 million in Q1 2026, up 188.17% quarter-over-quarter from $1.4 million in Q4 2025, and up 80960.0% on a YoY basis from N/an in Q1 2025.

Talphera (TLPH) Cash from Financing Activities (2010 - 2026) Analysis & Trends

Talphera's Cash from Financing Activities history runs 17 years deep, the most recent figure standing at $4.0 million for Q1 2026.

  • In Q1 2026, Cash from Financing Activities rose 80960.0% year-over-year to $4.0 million; the TTM figure through Mar 2026 stood at $26.8 million (up 107052.0% YoY), while the FY2025 annual figure was $22.7 million, up 88.81% from the prior year.
  • Cash from Financing Activities was $4.0 million for Q1 2026 at Talphera, up from $1.4 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $17.0 million in Q3 2025 to a low of -$3.3 million in Q2 2023.
  • Historically, Cash from Financing Activities has averaged $2.8 million across 5 years, with a median of $30000.0 in 2024.
  • The sharpest annual moves came in 2022 and 2026: Cash from Financing Activities plunged 106.09% in 2022, then soared 80960.0% in 2026.
  • A 5-year view of Cash from Financing Activities shows it stood at $5.3 million in 2022, then tumbled by 101.28% to -$68000.0 in 2023, then soared by 144.12% to $30000.0 in 2024, then jumped by 4576.67% to $1.4 million in 2025, then surged by 188.17% to $4.0 million in 2026.
  • The last three Cash from Financing Activities figures came in at $4.0 million (Q1 2026), $1.4 million (Q4 2025), and $17.0 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 13.00 Mn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn -840.00 Mn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn -1.48 Bn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn -86.10 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn -65.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 1.47 Bn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn -77.88 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn -11.62 Mn
10 Talphera 56.42 Mn 56.42 Mn - 4.04 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 4.04 Mn
Mar 31, 2026 4.04 Mn
Dec 31, 2025 1.40 Mn
Dec 31, 2025 1.40 Mn
Sep 30, 2025 16.99 Mn
Sep 30, 2025 16.99 Mn
Jun 30, 2025 4.35 Mn
Jun 30, 2025 4.35 Mn
Mar 31, 2025 -5,000.00
Mar 31, 2025 -5,000.00
Sep 30, 2024 30,000.00
Sep 30, 2024 30,000.00
Mar 31, 2024 12.01 Mn
Mar 31, 2024 12.01 Mn
Dec 31, 2023 -68,000.00
Dec 31, 2023 -68,000.00
Sep 30, 2023 8.94 Mn
Sep 30, 2023 8.94 Mn
Jun 30, 2023 -3.33 Mn
Jun 30, 2023 -3.33 Mn